
How the ‘Little Boy' Hiroshima nuclear bomb transformed modern warfare forever
Hiroshima, in Japan, was the target of the first ever nuclear weapon, dropped by the US Air Force on 7 August 1945 - killing more than 150,000 people in the months afterwards, according to some estimates.
Although victory had been declared in Europe four months earlier, American forces continued to fight Japan over the summer, in what would be the final months of the protracted Pacific War.
Just three days after the catastrophic nuclear attack on Hiroshima, Nagasaki met a similar fate. It had been just weeks since the first successful test of a nuclear weapon was masterminded by J. Robert Oppenheimer.
Eighty years later, The Independent takes a look at the direction nuclear warfare took after that seminal day - and how different nuclear weapons are now
How has the nuclear bomb developed since 1945?
Nicknamed 'Little Boy', the bomb dropped on Hiroshima exploded some 1,800 feet above the city, where it delivered around 12.5 kilotons of TNT.
Large sections of the city - five square miles - were razed to ashes. Within just four days, 120,000 people were killed, many instantly vaporised and others dying due to the impact of the burns and radiation in the days afterwards.
''Little Boy' was a gun-type weapon, which detonated by firing one mass of uranium down a cylinder into another mass to create a self-sustaining nuclear reaction,' the National Museum of the US Air Force explains. 'Weighing about 9,000 pounds (4.5 tons), it produced an explosive force equal to 20,000 tons of TNT [explosive].'
Delivered by the USAAF B29 bomber `Enola Gay', 'Little Boy' has now been entirely taken out of operational use - but its creation had set US and Russian scientists into a frantic race to develop the largest and most powerful nuclear weapons, in the largest quantities.
Seven years after the two Japanese cities were decimated by the atomic bomb, the US tested a brand new type of nuclear weapon: the hydrogen bomb.
First tested at Enewetak Atoll in the Marshall Islands, the hydrogen bomb was 500 times more powerful than the one used in Hiroshima. It is believed that many if not all current nuclear weapons in America's stockpile are hydrogen - or thermonuclear - weapons.
The largest ever bomb test was conducted by the Soviet Union, who tested a 58-megaton atmospheric nuclear weapon nicknamed the 'Tsar Bomb' near northern Russia.
In recent decades, following many years of international efforts to prevent the production of new nuclear weapons, the US has focussed on modernising its existing stockpile. According to the Bulletin of the Atomic Scientists (BAS), the US has begun a modernisation programme which will 'ultimately see every nuclear delivery system replaced with newer versions over the coming decades'.
How large have nuclear arsenals grown?
The Hiroshima bomb was dropped a mere three weeks after the Trinity test, the first successful test of a nuclear weapon the world had ever seen.
At the time, the American nuclear arsenal consisted of two weapons: the bombs which were used to destroy large areas of Hiroshima and Nagasaki, a catastrophe for the Japanese people, hundreds of thousands of whom were killed. But it was seen by some as one of the main reasons World War Two came to an end when it did.
Fast forward five years and the US had developed 299 more nuclear weapons, a nuclear arsenal nearly 60 times larger than that of the Soviet Union, which contained five, having tested its first nuclear bomb just one year earlier in 1949.
After a rapid period of dramatically increasing stockpiles during the Cold War saw the US stockpile hit a peak of 31,255 in 1961 and the Russian stockpile peak at 45,000 in 1986 - according to BAS estimates - numbers steadily decreased for decades.
The International Campaign to Abolish Nuclear Weapons (ICAN) says the US has approximately 5,044. Russia is estimated to have around 5,580, making it the world's largest stockpile. In descending order of the size of their arsenal, the other seven countries believed to have nuclear weapons are China, France, United Kingdom, Pakistan, India, Israel, North Korea. Not all of these countries openly admit they possess the weapons.
In the eight decades since the catastrophes in Hiroshima and Nagasaki, nuclear weapons have never been used in combat - but the incomparable destructiveness of hydrogen bombs and the sheer number of nuclear weapons in the world makes their risk far greater.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Guardian
2 hours ago
- The Guardian
Maglev train researchers may have solved ‘tunnel boom' shock waves
Researchers hope they may have solved the 'tunnel boom' problem as they prepare to roll out China's latest prototype magnetic levitation train. The newest version of the maglev train is capable of travelling at 600km/h (about 370mph). However, the train's engineers have wrestled with the problem of the shock waves which occur as the train exits the mouth of a tunnel. When a high-speed train enters an enclosed space such as a tunnel, air in front is compressed, like in a piston. The resulting fluctuations in air pressure coalesce at the tunnel mouth, generating low-frequency shock waves. These are colloquially known as a 'tunnel boom' – a related, albeit different phenomenon to the 'sonic boom' heard as aircraft pass the speed of sound. Tunnel booms pose serious challenges to operational safety, as the shock waves can disturb humans and animals nearby, as well as causing structural damage. Now, however, researchers have discovered that placing innovative soundproofing buffers at tunnel mouths can reduce shock waves by up to 96%. This promises improvements in operational safety, noise pollution and passenger comfort, as well as safeguarding animals in the vicinity of future lines. This was already a well documented problem for conventional high-speed trains, which travel at speeds of up to 350km/h (217mph), but it worsens significantly for trains travelling at even higher speeds because the strength of the shock wave increases rapidly and the critical length which gives rise to a tunnel boom drops off quickly. For example, a train travelling at 600km/h will lead to a boom in a tunnel just 2km (1.2 miles) long, while for conventional high-speed trains this happens only in tunnels which are 6km or longer. The porous structure of the new 100-metre long buffers, combined with porous coatings on the tunnel body, allow the trapped air to escape before the train reaches the tunnel mouth, suppressing the boom in the same way as a silencer fitted to a firearm. Magnetic levitation refers to the use of magnetic force to suspend a train above a guideway or rail, sometimes with a height of only 10mm, by either electromagnetic or electrodynamic suspension. The train is then propelled using other electromagnets. While conventional high-speed trains are ultimately limited in speed due to increased wear and tear of wheels against the track, the separation of track and train means that maglevs rise above such earthly concerns as friction. Electromagnetic suspension (EMS) has the train hugging a single steel rail with a U-shaped underside. When electromagnets connected to the train – positioned in the U-shape underneath the rail – are switched on, the train is levitated by a resultant attractive force between the train and rail. With electrodynamic suspension (EDS), the train sits in a U-shaped guideway, with superconducting coils embedded in guideway and train. When the power supply is switched on, magnetic poles are induced in the coils, leading to a combination of repulsive and attractive forces which enable the train to levitate. High-speed maglev trains made their debut in 2004 in China, running between Pudong airport and the outskirts of Shanghai at 460km/h (286mph), a speed record that still holds for rail vehicles in regular commercial service. Built using German 'Transrapid' technology, this service caters primarily to foreign travellers as local people prefer the much cheaper, albeit slower, metro. However, this initial hype was soon eclipsed, as subsequent development of China's rail network focused entirely on conventional high-speed rail. The national network is now the world's largest in length at 48,000km (30,000 miles), with more lines under construction. But maglev trains are now making a comeback under the state-owned manufacturer CRRC, which launched the new model in 2021. There is no mechanical noise, passengers describing the quiet hum of electromagnets and a ride smoother than a conventional train. Sign up to Down to Earth The planet's most important stories. Get all the week's environment news - the good, the bad and the essential after newsletter promotion Although no lines have yet been formally planned, it is widely expected that a future line will connect the capital, Beijing, with cosmopolitan Shanghai, reducing journey times from 4.5 hours to 2.5 hours, about the duration of a domestic flight between the two cities. In China, the cost of a high-speed rail ticket is cheaper than air travel (¥600 compared with ¥1,200), unlike in many other countries. Flights emit on average seven times more CO2 than high-speed rail by distance travelled, representing a big potential carbon saving. China is not the only place where long-distance high-speed maglevs are on the horizon. Japan also has its hopes pinned on the Chuo Shinkansen, which will link its two biggest cities of Tokyo and Osaka via Nagoya, cutting through the heart of the country. The Tokaido Shinkansen, a conventional high-speed rail line, does this journey in 2.5 hours, but it is hoped that the new maglev line travelling at 505km/h (314mph) will reduce this to just 67 minutes. It was originally scheduled to begin partial service in 2027, but inevitable delays have encumbered the project, with a new opening date uncertain.


The Independent
2 hours ago
- The Independent
Great Barrier Reef records largest annual coral loss in 39 years
The Great Barrier Reef has experienced its greatest annual loss of live coral across most of its expanse in four decades of record-keeping, Australian authorities say. But due to increasing coral cover since 2017, the coral deaths — caused mainly by bleaching last year associated with climate change — have left the area of living coral across the iconic reef system close to its long-term average, the Australian Institute of Marine Science said in its annual survey on Wednesday. The change underscores a new level of volatility on the UNESCO World Heritage Site, the report said. Mike Emslie, who heads the tropical marine research agency's long-term monitoring program, said the live coral cover measured in 2024 was the largest recorded in 39 years of surveys. The losses from such a high base of coral cover had partially cushioned the serious climate impacts on the world's largest reef ecosystem, which covers 344,000 square kilometers (133,000 square miles) off the northeast Australian coast, he said. 'These are substantial impacts and evidence that the increasing frequency of coral bleaching is really starting to have detrimental effects on the Great Barrier Reef,' Emslie said on Thursday. 'While there's still a lot of coral cover out there, these are record declines that we have seen in any one year of monitoring,' he added. Emslie's agency divides the Great Barrier Reef, which extends 1,500 kilometers (900 miles) along the Queensland state coast, into three similarly-sized regions: northern, central and southern. Living coral cover shrunk by almost a third in the south in a year, a quarter in the north and by 14% in the central region, the report said. Because of record global heat in 2023 and 2024, the world is still going through its biggest — and fourth ever recorded — mass coral bleaching event on record, with heat stress hurting nearly 84% of the world's coral reef area, including the Great Barrier Reef, according to the U.S. National Oceanic and Atmospheric Administration's coral reef watch. So far at least 83 countries have been impacted. This bleaching event started in January 2023 and was declared a global crisis in April 2024. It easily eclipsed the previous biggest global coral bleaching event, from 2014 to 2017, when 68.2% had bleaching from heat stress. Large areas around Australia — but not the Great Barrier Reef — hit the maximum or near maximum of bleaching alert status during this latest event. Australia in March this year started aerial surveys of 281 reefs across the Torres Strait and the entire northern Great Barrier Reef and found widespread coral bleaching. Of the 281 reefs, 78 were more than 30% bleached. Coral has a hard time thriving and at times even surviving in prolonged hot water. They can survive short bursts, but once certain thresholds of weeks and high temperatures are passed, the coral is bleached, which means it turns white because it expels the algae that live in the tissue and give them their colors. Bleached corals are not dead, but they are weaker and more vulnerable to disease. Coral reefs often bounce back from these mass global bleaching events, but often they are not as strong as they were before. Coral reefs are considered a 'unique and threatened system' due to climate change and are especially vulnerable to global warming beyond 1.5 degrees Celsius (2.7 degrees Fahrenheit) since pre-industrial times, the United Nations Intergovernmental Panel on Climate Change proclaimed in 2018. The world has now warmed 1.3 degrees Celsius since pre-industrial times. That report said 'tropical corals may be even more vulnerable to climate change than indicated in assessments made in 2014.' The report said back-to-back big bleaching events at the Great Barrier Reef in the mid 2010s 'suggest that the research community may have underestimated climate risks for coral reefs.' 'Warm water (tropical) coral reefs are projected to reach a very high risk of impact at 1.2°C, with most available evidence suggesting that coral-dominated ecosystems will be non-existent at this temperature or higher. At this point, coral abundance will be near zero at many locations,' the report said. ____ Associated Press Science Writer Seth Borenstein in Washington, D.C., contributed to this report.


Daily Mail
4 hours ago
- Daily Mail
Pill that costs just pennies a day linked to decreased risk of dementia, study suggests
Doctors are zeroing in on ways to prevent dementia, and the secret weapon could be an inexpensive drug that has served as the backbone for diabetes treatment for decades. Long before Ozempic splashed onto the scene, transforming type 2 diabetes treatment, there was metformin. Used for about 100 years, metformin lowers the amount of sugar the liver pumps out and helps the body respond to insulin better. It has been the first-line treatment for more than 70 percent of people newly diagnosed with type 2 diabetes. Doctors have suggested through observational studies for several years that the mainstay of diabetes, which roughly 19 million people take for $2 to $20 per month, could have preventive power. Still, evidence has been mixed, with some studies suggesting the drug exacerbates the development of Alzheimer's disease, just one type of dementia, and several others saying it has a protective effect on the brain. Now, doctors from Taipei Medical University in Taiwan are the latest to make the case for the latter. They found that, in half a million overweight and obese people without diabetes, those who took metformin had a lower risk of developing dementia or dying from any cause, regardless of their BMI. Similar to type 2 diabetes, obesity is a risk factor for dementia. Being severely overweight lowers the body's defenses against the damage dementia inflicts on the brain and causes chronic inflammation, potentially damaging nerve cells. Until now, research into metformin as a dementia preventative has primarily focused on people with diabetes. The latest report from Taiwanese researchers is the first to use real-world data to investigate the possibility in people with obesity. The scientists noted the real-world data reflects a diverse population, making the study's findings widely applicable. They used an electronic health records database covering millions of patients from 66 US healthcare systems, including hospitals, specialty centers, and clinics. The researchers said: 'Since central nervous system inflammation and neuroinflammation are crucial factors in the development and progression of neurodegenerative diseases, the anti-inflammatory and antioxidative effects of metformin are especially beneficial in patients with obesity. 'Regular, long-term use of metformin may be an efficient way to prevent dementia.' The study included about 905,000 people in total, split evenly into two groups: those on and those not on metformin. They were matched to be similar in age, health, and other factors for a fair comparison. The metformin group had been prescribed the drug at least twice in their lives for at least six months. The study did not explicitly state why people had been prescribed the drug, but it can be used to treat more than just diabetes, such as prediabetes, those with a metabolic disorder that contributes to obesity, and for polycystic ovary syndrome. Researchers categorized their study subjects, all adults over 18, into four groups: overweight (BMI 25–29.9), Obese class I (BMI 30–34.9), Obese class II (BMI 35–39.9) and morbidly obese (BMI over 40). After following patients for 10 years, those who took metformin had a lower risk of developing dementia across all BMI groups. The amount of risk reduction varied slightly depending on weight, but two of the groups saw significant results. People with a BMI of 30 to 34.9 had a dementia risk about eight percent lower than non-users, while those with a BMI between 25 and 29.9 had a risk about 12.5 percent lower. People with a BMI of 35 to 39.9 had a four percent lower risk, which researchers deemed statistically insignificant, potentially due to a smaller sample size. There was no significant difference in people with a BMI over 40. When looking at death from any cause, metformin users also had a significantly lower risk across all BMI categories. Metformin's effect on death risk was stronger than its effect on dementia risk. Those with a BMI between 25 and 29.9 had a 28 percent lower risk of death, while those with a BMI of 30 to 34.9 had a 27 percent lower risk. People with a BMI of 35 to 39.9 had a 28 percent lower risk of death, and people with a BMI of 40 or above saw a 26 percent lower risk. The Taipei team's findings were published in the journal Diabetes, Obesity and Metabolism. Scientists attribute metformin's recently explored impact on cognitive health and dementia to factors unique to the drug and the condition it treats. A type 2 diabetes diagnosis is a leading risk factor for dementia, with one sweeping review in 2013 finding that diabetes patients have a 73 percent higher likelihood of developing dementia and a 56 percent higher likelihood of developing Alzheimer's. Both conditions affect millions in the US. Around 35 million Americans have type 2 diabetes, while an estimated 7million have dementia, including roughly four to 6 million with Alzheimer's disease. Several studies have resulted in compelling evidence that supports metformin's anti-dementia abilities. In 2020, Australian researchers followed over 1,000 dementia-free seniors aged 70 to 90 from Sydney for up to six years, testing their memory and thinking skills at two and six years. The study looked at three main groups: people with type 2 diabetes who were taking metformin, those with diabetes who were not, and people without diabetes. The participants in the study, who did not have dementia at the start, were tested at two years and again at six years for their in-depth memory and executive functioning. After accounting for other health factors, researchers found that the metformin group had an 81 percent lower risk of dementia compared to those with diabetes who weren't on metformin. People with diabetes who didn't take metformin were nearly three times more likely to develop dementia than people without diabetes. Brain scans and thinking tests also suggested that metformin users experienced a slower decline in cognitive abilities, particularly in decision-making and overall brain function.